Help
Subscribe


All of GastroHep is now free access! - Click here to register Read For FREE - Our full range of review articles
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Guido Tytgat Profile of Pete Peterson Profile of Peter Cotton Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Online tool to manage iron deficiency in inflammatory bowel disease

The latest issue of the Alimentary Pharmacology & Therapeutics investigates the use of an online tool developed by the RAND/UCLA appropriateness method for the management of iron deficiency in IBD.

News image

Iron deficiency is a common and undertreated problem in inflammatory bowel disease (IBD).

Professor Reinisch and colleagues from Austria developed an online tool to support treatment choice at the patient-specific level.

Using the RAND/UCLA Appropriateness Method (RUAM), a European expert panel assessed the appropriateness of treatment regimens for a variety of clinical scenarios in patients with non-anemic iron deficiency (NAID) and iron deficiency anemia.

Treatment options included adjustment of IBD medication only, oral iron supplementation, high-/low-dose intravenous regimens, IV iron plus erythropoietin-stimulating agent, and blood transfusion.

The panel process consisted of 2 individual rating rounds, and 3 plenary discussion meetings.

For 98% of scenarios, at least 1 treatment was appropriate
Alimentary Pharmacology & Therapeutics

The panel reached agreement on 71% of treatment indications.

The research team reported that ‘No treatment’ was never considered appropriate, and repeat treatment after previous failure was generally discouraged.

The team found that for 98% of scenarios, at least 1 treatment was appropriate.

Adjustment of IBD medication was deemed appropriate in all patients with active disease.

The team reported that use of oral iron was mainly considered an option in NAID and mildly anemic patients without disease activity.

IV regimens were often judged appropriate, with high-dose IV iron being the preferred option in 77% of  iron deficiency anemia scenarios.

Blood transfusion and intravenous plus erythropoietin-stimulating agent were indicated in exceptional cases only.

Professor Reinisch's team concluded, "The RUAM revealed high agreement amongst experts on the management of iron deficiency in patients with IBD."

"High-dose IV iron was more often considered appropriate than other options."

"To facilitate dissemination of the recommendations, panel outcomes were embedded in an online tool, accessible via http://ferroscope.com/."

Aliment Pharmacol Ther 2013: 38(9): 1109–1118
23 October 2013

Go to top of page Email this page Email this page to a colleague

 19 April 2015

Advanced search
 17 April 2015 
MELD score and colorectal resection
 17 April 2015 
Synchronous colorectal advanced neoplasia
 17 April 2015 
PNPLA3 polymorphisms and NAFLD risk
 16 April 2015 
Bleeding risk in colonic diverticulosis
 16 April 2015 
Minority use of high-volume hospitals for colorectal cancer
 16 April 2015 
Sleep and IBD
 15 April 2015 
Treatment of hepatocellular carcinoma
 15 April 2015 
Score predicts malignant bile duct obstruction
 15 April 2015 
Increased risk of Barrett esophagus
 14 April 2015 
Improving colorectal cancer screening uptake
 14 April 2015 
Colorectal cancer presenting under the age of 50
 14 April 2015 
Functional constipation vs constipation predominant IBS
 13 April 2015 
Fecal transplant for C. difficile
 13 April 2015 
CRP and acute diverticulitis
 13 April 2015 
Immune based treatments for HCC
 10 April 2015 
Hypnotherapy for IBS
 10 April 2015 
Adjuvant therapy after rectal cancer
 10 April 2015 
Viral outcomes in HCV infection
 09 April 2015 
Male IBD patients wishing to conceive
 09 April 2015 
Screening programs based on the fecal immunochemical test
 09 April 2015 
Management of esophageal food impaction
 08 April 2015 
Nonceliac gluten sensitivity
 08 April 2015 
Ambulatory hemorrhoidal surgery
 08 April 2015 
Iron fortification and gut inflammation
 07 April 2015 
Endoscopic managements of GI bleeds
 07 April 2015 
Interventions for eosinophilic esophagitis
 07 April 2015 
Treatment of Hep C virus
 06 April 2015 
Treatment for rectal cancer
 06 April 2015 
Risk stratifying Barrett's esophagus
 06 April 2015 
Cost-effectiveness of HCV
 03 April 2015 
Predicting advanced cancer in Barrett's
 03 April 2015 
Vitamin D deficiency and Hep B outcomes
 03 April 2015 
Hepatocellular carcinoma surveillance in cirrhosis
 02 April 2015 
Physical activity and NAFLD
 02 April 2015 
Genetic risk for Crohn's disease
 02 April 2015 
EUS for detection of pancreatic neuroendocrine tumors
 01 April 2015 
Obeticholic acid in primary biliary cirrhosis
 01 April 2015 
Analysis of liver fibrosis
 01 April 2015 
Mortality rates for upper GI bleeds
 31 March 2015 
Placement of nasoenteral feeding tubes
 31 March 2015 
HCV-HIV co-infection combination therapy
 31 March 2015 
Hepatic fat and gallbladder polyps
 30 March 2015 
Treatment of pediatric IBD
 30 March 2015 
Minimally invasive approach in colorectal procedures
 30 March 2015 
Prevalence of IBD in USA residents of Indian ancestry
 27 March 2015 
Screening for fecal incontinence
 27 March 2015 
Deep remission in Crohn's disease
 27 March 2015 
Sexual functioning in IBD
 26 March 2015 
Antimicrobial therapy in cirrhosis with spontaneous bacterial peritonitis
 26 March 2015 
Metformin as a chemopreventive agent for Barrett's
 26 March 2015 
Survival of untreated hepatocellular carcinoma
 25 March 2015 
Cytomegalovirus and IBD
 25 March 2015 
Genetics and Crohn's disease
 25 March 2015 
Mortality in Barrett’s–related T1 esophageal adenocarcinoma
 24 March 2015 
Prevention of colorectal cancer after screening
 24 March 2015 
Functional GI disorders and body mass index
 24 March 2015 
Quality of life in children with fecal incontinence
 23 March 2015 
Fibrosis in NAFLD vs NASH
 23 March 2015 
The unmasking of Whipple's disease
 23 March 2015 
Predicting the quality of colon cancer care

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2015 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us